• MSH6 Gene Mutation Analysis (Known Mutations, Duplication/Deletion/Sequencing)
  • Malignant neoplasm, pancreas
  • Fibrinogen (Functional)
  • Postmeiotic Segregation Increased 2 (PMS2) Gene Mutation Analysis
  • Oncology Pharmacogenetics (PGx) Gene Variation Panel
  • Inhibitor Screen (1:1 Mix), Mixing Studies
  • Acute myeloid leukemia (AML)
  • Bilirubin Total, Serum
  • Coagulation Factor VIII Activity Assay, Plasma
  • The BT-Reveal Early Pancreatic Cancer Test
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /FoundationOne®CDx (F1CDx) and FoundationOne® Liquid CDx
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

FoundationOne®CDx (F1CDx) and FoundationOne® Liquid CDx
Medical Test

Interpretation
Access to FoundationOne®CDx (F1CDx) and FoundationOne® Liquid CDx is restricted.
Loading...